Exhibit 4.3
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
REASONABLY ACCEPTABLE TO THE COMPANY TO SUCH EFFECT, THE SUBSTANCE OF WHICH
SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY MAY BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR
OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN "ACCREDITED INVESTOR" AS
DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT.
BIO-LIFE LABS, INC.
WARRANT AGREEMENT and paper certificate, dated May 20, 2005 (the "Agreement"),
by and between Bio-Life Labs, Inc. , a Nevada corporation (the "Company"), and
Xxxxx and Xxxxxxxx Xxxxx the holder of warrants to purchase 1,250,000 shares of
the Company's common stock exercisable for a period of three years at a price of
$0.20 per share individually a "Holder") and callable by the Company at $0.20 if
the Company's bid price closes at or greater than $0.50 per share for 30
consecutive days, with all such underlying shares to have demand registration
rights.
COMMON STOCK PURCHASE WARRANT
To Purchase 1,250,000 Shares of Common Stock of
THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") CERTIFIES that, for
value received, Xxxxx and Xxxxxxxx Xxxxx (the "Holder"), is entitled, upon the
terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date of issuance of this Warrant (the
"Exercise Date") and on or prior to the third anniversary of the Exercise Date
(the "Termination Date") but not thereafter, to subscribe for and purchase from
Bio-Life Labs, Inc. , a Nevada corporation (the "Company"), up to 1,250,000
shares (the "Warrant Shares") of Common Stock, par value $0.001 per share, of
the Company (the "Common Stock"). The purchase price of one share of Common
Stock (the "Exercise Price") under this Warrant shall be $0.20, subject to
adjustment hereunder. The Exercise Price and the number of Warrant Shares for
which the Warrant is exercisable shall be subject to adjustment as provided
herein. This Warrant is callable by the Company at any time if the Company's bid
price closes at or greater than $0.50 for 30 consecutive days. The Holder shall
have registration rights. A registration statement on a Form SB-2 must be filed
on or before November 30, 2005 for all underlying shares. In the event that
Holder exercises its Option, defined herein, the registration date shall be
extended. Holder is hereby granted the option by the Company to invest in up to
50% of a subsequent offering that closes on or before November 30, 2005, with
registration rights and whatever terms are negotiated in that offering ("the
Option") and if such Option is exercised, all Holder's underlying shares herein,
including Shares and Warrants purchased on or about May 20, 2005, shall be
registerable on or before January 31, 2006.
NOW, THEREFORE, in consideration of the premises and the mutual covenants
contained herein, the Company and the Holder hereby agree as follows:
1. Exercise of Warrant.
(a) This warrant (the "Warrant") shall entitle the Holder thereof to
purchase an aggregate of 1,250,000 shares of Common Stock at an exercise price
of $0.20 (the "Exercise Price") per share. The Warrants may be exercised in
whole or in part, at any time or from time to time during the period commencing
on June 20, 2005 and expiring at 5:00 p.m., New York City time, on June 19, 2008
(the "Exercise Term"), or if such day is a day on which banking institutions in
the State of New York are authorized by law to close, then on the next
succeeding day which shall not be such a day, by presentation and surrender of
the Warrant Certificate evidencing the Warrant to be exercised to the Company at
its principal office or at the office of its stock transfer agent, if any, with
the Exercise Form annexed hereto duly executed and accompanied by payment of the
Exercise Price for the number of shares specified in such form. If any Warrant
should be exercised in part only, the Company shall, upon surrender of the
Warrant Certificates for cancellation and presentment of the Exercise Form,
execute and deliver new a Warrant Certificate or Certificates, as the case may
be, evidencing the rights of the Holder thereof to purchase the balance of the
shares purchasable thereunder. Upon receipt by the Company of a Warrant
Certificate at its office, or by the stock transfer agent of the Company at its
office, in proper form for exercise and accompanied by the appropriate payment
for the shares of Common Stock underlying the Warrants (the "Warrant Shares"),
the Holder shall be deemed to be the holder of record of such Warrant Shares,
notwithstanding that the stock transfer books of the Company shall then be
closed or that certificates representing such Warrant Shares shall not then be
actually delivered to the Holder. Certificates for the Warrant Shares shall be
delivered to the Holder within a reasonable time following the exercise of the
Warrants in accordance with the foregoing.
2. Alternative Exercice Provisions. Anything contained herein to the
contrary notwithstanding, provided that the shares underlying this Warrant have
been registered, the Holder, at his option, may exercise the Warrants, in whole
or in part, during the Exercise Term by delivering to the Company a confirmation
slip issued by a brokerage firm that is a member of the National Association of
Securities Dealers, Inc. with respect to the sale of those number of Warrant
Shares for which the Warrants are being exercised, and, in such case, the
Company shall deliver certificates representing such Warrant Shares on
settlement date at the office of the Company's stock transfer agent against
payment for such Warrant Shares by such brokerage firm or its clearing broker,
made payable to the Company or made payable to the order of the Holder and
endorsed by the Holder to the Company.
2
3. Reservation and Listing of Shares. The Company hereby agrees that at all
times there shall be reserved for issuance and delivery upon exercise of the
Warrants, such number of shares of its Common Stock as shall be required for
issuance and delivery upon exercise of the Warrants. As long as the Warrants
shall be outstanding, the Company shall use its best efforts to cause all shares
of Common Stock issuable upon the exercise of the Warrants to be listed on the
Over The Counter Bulletin Board or on Nasdaq or a national securities exchange,
if such shares of Common Stock, as a class, are theretofore so listed.
4. Fractional Shares. No tractional shares or scrip representing fractional
shares shall be issued upon the exercise of the Warrants. Any fraction of a
share called for upon any exercise hereof shall be canceled. The Holder, by his
acceptance hereof, expressly waives any right to receive any fractional share of
stock or fractional Warrant upon exercise of the Warrants.
5. Exchange. Transfer. Assignment or Loss of Warrant. The Warrants are
exchangeable, without expense, at the option of the Holder, upon presentation
and surrender of the Warrant Certificates evidencing such Warrants to the
Company at its office or at the office of its stock transfer agent, if any, for
other Warrants of different denominations entitling the Holder thereof to
purchase in the aggregate the same number of shares of Common Stock as are
purchasable thereunder at the same respective Exercise Price. Subject to Section
10 hereof, upon surrender of the Warrant Certificates to the Company at its
principal office or at the office of its stock transfer agent, if any, with a
duly executed Assignment Form which is annexed hereto and funds sufficient to
pay the applicable transfer tax, if any, the Company shall, without charge,
execute and deliver new Warrant Certificates in the name of the assignee named
in such instrument of assignment and the original Warrant Certificate shall
promptly be canceled. The Warrants may be divided or combined with other
Warrants which carry the same rights upon presentation of the Warrant
Certificate evidencing such Warrants at the office of the Company or at the
office of its stock transfer agent, if any, together with a written notice
signed by the Holder hereof specifying the names and denominations in which new
Warrant Certificates are to be issued. Upon receipt by the Company of evidence
satisfactory to it of the loss, theft, destruction or mutilation of the
Warrants, and, in the case of loss, theft or destruction, of reasonably
satisfactory indemnification, and upon surrender and cancellation of the
Warrants, if mutilated, the Company will execute and deliver new Warrant
Certificates of like tenor and date. Any such new Warrant Certificates, when
executed and delivered, shall constitute an additional contractual obligation on
the part of the Company, whether or not the Warrant Certificates so lost,
stolen, destroyed, or mutilated shall be at any time enforceable by anyone
6. Rights of the Holder. The Holder shall not, by virtue hereof, be
entitled to any rights of a shareholder of the Company until exercise of any
Warrants.
7. Adjustments of Purchase Price and Number of Shares.
(a) Subdivision and Combination. In case the Company shall at any time
subdivide or combine the outstanding shares of Common Stock by way of stock
split, reverse stock split or the like, the Exercise Prices shall forthwith be
proportionately increased or decreased.
3
(b) Adjustment in Number of Shares. Upon each adjustment of the Exercise
Price pursuant to the provisions of this Section 7, the number of Shares
issuable upon the exercise of each Warrant shall be adjusted to the nearest full
Share by multiplying a number equal to the Exercise Price in effect immediately
prior to such adjustment by the number of Shares issuable upon exercise of the
Warrants immediately prior to such adjustment and dividing the product so
obtained by the adjusted Exercise Price.
(c) Reclassification. Consolidation. Merger. etc. In case of any
reclassification or change of the outstanding shares of Common Stock (other than
a change in par value to no par value, or from no par value to par value, or as
a result of a subdivision or combination), or in the case of any consolidation
of the Company with, or merger of the Company into, another corporation (other
than a consolidation or merger in which the Company is the surviving corporation
and which does not result in any reclassification or change of the outstanding
shares of Common Stock, except a change as a result of a subdivision or
combination of such shares or a change in par value, as aforesaid), or in the
case of a sale or conveyance to another corporation of all or a substantial part
of the property of the Company, the Holder shall thereafter have the right to
purchase the kind and number of shares of stock and other securities and
property receivable upon such reclassification, change, consolidation, merger,
sale or conveyance as if the Holder were the owner of the shares of Common Stock
underlying the Warrants immediately prior to any such events at a price equal to
the product of (x) the number of shares issuable upon exercise of the Warrants
and (y) the Exercise Price in effect immediately prior to the record date for
such reclassification, change, consolidation, merger, sale or conveyance as if
such Holder had exercised the Warrants.
(d) Dividends and Other Distributions with Respect to Outstanding
Securities. In the event that the Company shall at any time prior to the
exercise of all Warrants declare a dividend (other than a dividend consisting
solely of shares of Common Stock or a cash dividend or distribution payable out
of current or retained earnings) or otherwise distribute to its shareholders any
monies, assets, property, rights, evidences of indebtedness, securities (other
than shares of Common Stock), whether issued by the Company or by another person
or entity, or any other thing of value, the Holder of the unexercised Warrants
shall thereafter be entitled, in addition to the shares of Common Stock or other
securities receivable upon the exercise thereof, to receive, upon the exercise
of such Warrants, the same monies, property, assets, rights, evidences of
indebtedness, securities or any other thing of value that they would have been
entitled to receive at the time of such dividend or distribution. At the time of
any such dividend or distribution, the Company shall make appropriate reserves
to ensure the timely performance of the provisions of this Subsection 7(d).
(e) Warrant Certificate After Adjustment. Irrespective of any change
pursuant to this Section 7 in the Exercise Price or in the number, kind or class
of shares or other securities or other property obtainable upon exercise of the
Warrants, the Warrants may continue to express as the Exercise Price and as the
number of shares obtainable upon exercise, the same price and number of shares
as are stated herein.
(f) Statement of Calculation. Whenever the Exercise Price shall be
adjusted pursuant to the provisions of this Section 7, the Company shall
forthwith file at its principal office, a statement signed by an executive
officer of the Company specifying the adjusted Exercise Price determined as
above provided in
4
such section. Such statement shall show in reasonable detail the method of
calculation of such adjustment and the facts requiring the adjustment and upon
which the calculation is based. The Company shall forthwith cause a notice
setting forth the adjusted Exercise Price to be sent by certified mail, return
receipt requested, postage prepaid, to the Holder.
8. Definition of "Common Stock." For the purpose of the Warrants, the term
"Common Stock" shall mean, in addition to the class of stock designated as the
Common Stock, $.001 par value, of the Company on the date hereof, any class of
stock resulting from successive changes or reclassifications of the Common Stock
consisting solely of changes in par value, or from par value to no par value, or
from no par value to par value. If at any time, as a result of an adjustment
made pursuant to one or more of the provisions of Section 7 hereof, the shares
of stock or other securities or property obtainable upon exercise of the
Warrants shall include securities of the Company other than shares of Common
Stock or securities of another corporation, then thereafter the amount of such
other securities so obtainable shall be subject to adjustment from time to time
in a manner and upon terms as nearly equivalent as practicable to the provisions
with respect to Common Stock contained in Section 7 hereof and all other
provisions of the Warrants with respect to Common Stock shall apply on like
terms to any such other shares or other securities.
9. Registration Under the Securities Act of 1933. The Investor will be
entitled to "piggy-back" registration rights of the Warrant Shares issuable upon
exercise of the Warrant on registration statements (other than on Form S-8, S-4
or similar Forms) filed by the Company. The Company shall file a registration
statement on or before November 30, 2005 registering the shares issued to the
Investor pursuant to this Subscription Agreement. A registration statement must
be filed on or before November 30, 2005 for all Shares and shares underlying the
Warrants, but in the event that Holder exercises its option, defined below in
paragraph number 6, the registration date shall be extended. In the event that
the Company does not file the registration statement, registering the shares
purchased hereunder on or before November 30, 2005 (or January 31, 2006 if such
period has been extended pursuant to the terms of this subscription agreement),
the Company shall pay Investor 50,000 shares of common stock and 25,000
warrants, on the same terms as the warrants issued hereunder, for each month
that the registration statement is not filed.
10. Transfer to Comply with the Act. Neither Warrants nor the Warrant
Shares nor any other security issued or issuable upon exercise of the Warrants
may be sold or otherwise disposed of except as follows:
(a) to a person who, in the opinion of counsel for the Company, is a
person to whom the Warrants or Warrant Shares may legally be transferred without
registration and without the delivery of a current prospectus under the Act with
respect thereto and then only against receipt of a letter from such person in
which such person represents that he is acquiring the Warrants or Warrant Shares
for his own account for investment purposes and not with a view to distribution
and provides any other information and representations required by the Company,
and in which such person agrees to comply with the provisions of this Section 10
with respect to any resale or other disposition of such securities; or
5
(b) to any person upon delivery of a prospectus then meeting the
requirements of the Act relating to such securities and the offering thereof for
such sale or disposition.
11. Notices to Warrant Holders. Nothing contained in this Agreement shall
be construed as conferring upon the Holder or Holders the right to vote or to
consent or to receive notice as a shareholder in respect of any meetings of
shareholders for the election of directors or any other matter, or as having any
rights whatsoever as a shareholder of the Company. If, however, at any time
prior to the expiration of the Warrants and their exercise, any of the following
events shall occur:
(a) The Company shall take a record of the holders of its shares of
Common Stock for the purpose of entitling them to receive a dividend or
distribution payable otherwise than in cash, or a cash dividend or distribution
payable otherwise than out of current or retained earnings, as indicated by the
accounting treatment of such dividend or distribution on the books of the
Company; or
(b) The Company shall offer to all the holders of its Common Stock any
additional shares of capital stock of the Company or securities convertible into
or exchangeable for shares of capital stock of the Company, or any warrant,
right or option to subscribe therefor; or
(c) A dissolution, liquidation or winding up of the Company (other than
in connection with a consolidation or merger) or a sale of all or substantially
all of its property, assets and business shall be proposed; or
(d) There shall be any capital reorganization or reclassification of the
capital stock of the Company, or consolidation or merger of the Company with
another entity, then, in anyone or more of said events, the Company shall give
written notice of such event at least fifteen (15) days prior to the date fixed
as a record date or the date of closing the transfer books for the determination
of the shareholders entitled to such dividend, distribution, convertible or
exchangeable securities or subscription rights, warrants or options, or entitled
to vote on such proposed dissolution, liquidation, winding up or sale. Such
notice shall specify such record date or the date of closing the transfer books,
as the case may be. Failure to give such notice or any defect therein shall not
affect the validity of any action taken in connection with the declaration or
payment of any such dividend or distribution, or the issuance of any convertible
or exchangeable securities or subscription rights, warrants or options, or any
proposed dissolution, liquidation, winding up or sale.
12. Notices.
(a) All communications under this Agreement shall be in writing and
shall be mailed by certified mail, postage prepaid, return receipt requested, or
telecopied with confirmation of receipt or delivered by hand or by overnight
delivery service:
6
If to the Company, at:
Bio-Life Labs, Inc.
00 Xxxxxxx Xxxx
Xx Xxxx, Xxxxx 00000
Attn: Xxxxx Xxxxx, President
If to the Holder, to the address of such Holder
as it appears in the stock or warrant ledger of
the Company.
(b) Any notice so addressed, when mailed by registered or certified mail
shall be deemed to be given three days after so mailed, when telecopied shall be
deemed to be given when transmitted, or when delivered by hand or overnight
shall be deemed to be given when hand delivered or on the day following deposit
with the overnight delivery service.
13. Successors. All the covenants and provisions of this Warrant Agreement
by or for the benefit of the Holder shall inure to the benefit of his successors
and assigns hereunder.
14. Termination. This Warrant Agreement will terminate on the earlier of
(a) the expiration date of the Warrants or (b) the date all of the Warrants
shall have been exercised.
15. Governing Law. This Warrant Agreement shall be deemed to be made under
the laws of the State of New York and for all purposes shall be construed in
accordance with the laws of said State, excluding choice of law principles
thereof.
16. Entire Agreement: Amendment: Waiver. This Warrant Agreement and all
attachments hereto and all incorporation by references set forth herein, set
forth the entire agreement and understanding between the parties as to the
subject matter hereof and merges and supersedes all prior discussions,
agreements and understandings of any and every nature among them. This Warrant
Agreement may be amended, the Company may take any action herein prohibited or
omit to take any action herein required to be performed by it, and any breach of
any covenant, agreement, warranty or representation may be waived, only if the
Company has obtained the written consent or waiver of the Holder. No course of
dealing between or among any persons having any interest in this Warrant
Agreement will be deemed effective to modify, amend or discharge any part of
this Warrant Agreement or any rights or obligations of any person under or by
reason of this Warrant Agreement.
7
BIO-LIFE LABS, INC.
By: ___________________________
Name:
Title:
Dated: June 20, 2005
Attest:
________________________________
8
